Skip to content

Frontlight ResearchEarly access

Trial site

Centrum Zdrowia MDM (Site 1512)

Warsaw, Masovian Voivodeship 00-189, PolandEU-13 widening countryNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Ulcerative colitis

Running trials

Active, not recruiting
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
NCT06052059· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Centrum Zdrowia MDM (Site 1512): trial site – Frontlight Research